Structure-based pharmacophore modeling 2. Developing a novel framework for structure-based pharmacophore model generation and selection

被引:1
|
作者
Szwabowski, Gregory L. [1 ]
Daigle, Bernie J. [2 ,3 ]
Baker, Daniel L. [1 ]
Parrill, Abby L. [1 ]
机构
[1] Univ Memphis, Dept Chem, Memphis, TN 38152 USA
[2] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA
[3] Univ Memphis, Dept Comp Sci, Memphis, TN 38152 USA
关键词
Pharmacophore modeling; Ligand identification; Ligand discovery; Structure-based pharmacophore; GPCR; PROTEIN-COUPLED RECEPTORS; OPIOID RECEPTOR; CRYSTAL-STRUCTURE; DRUG DISCOVERY; ADENOSINE A(1); FINGERPRINTS; CHALLENGES; COMPLEX; TARGETS; LIGAND;
D O I
10.1016/j.jmgm.2023.108488
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Pharmacophore models are three-dimensional arrangements of molecular features required for biological activity that are used in ligand identification efforts for many biological targets, including G protein-coupled receptors (GPCR). Though GPCR are integral membrane proteins of considerable interest as targets for drug development, many of these receptors lack known ligands or experimentally determined structures necessary for ligand-or structure-based pharmacophore model generation, respectively. Thus, we here present a structure-based pharmacophore modeling approach that uses fragments placed with Multiple Copy Simultaneous Search (MCSS) to generate high-performing pharmacophore models in the context of experimentally determined, as well as modeled GPCR structures. Moreover, we have addressed the oft-neglected topic of pharmacophore model se-lection via development of a cluster-then-predict machine learning workflow. Herein score-based pharmaco-phore models were generated in experimentally determined and modeled structures of 13 class A GPCR and resulted in pharmacophore models exhibiting high enrichment factors when used to search a database containing 569 class A GPCR ligands. In addition, classification of pharmacophore models with the best performing cluster-then-predict logistic regression classifier resulted in positive predictive values (PPV) of 0.88 and 0.76 for selecting high enrichment pharmacophore models from among those generated in experimentally determined and modeled structures, respectively.
引用
下载
收藏
页数:17
相关论文
共 50 条
  • [41] Potential inhibitors of methionine aminopeptidase type II identified via structure-based pharmacophore modeling
    Albayati, Safana
    Uba, Abdullahi Ibrahim
    Yelekci, Kemal
    MOLECULAR DIVERSITY, 2022, 26 (02) : 1005 - 1016
  • [42] Hit identification of SMYD3 enzyme inhibitors using structure-based pharmacophore modeling
    Alnabulsi, Soraya M.
    Al-shar'i, Nizar A.
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (10) : 1107 - 1117
  • [43] Pharmacophore Modeling Using a Reduced Protein Representation as a Tool for Structure-Based Protein Function Prediction
    Reyes, Vicente M.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2009, 26 (06): : 873 - 873
  • [44] Ligand-based autotaxin pharmacophore models reflect structure-based docking results
    Mize, Catrina D.
    Abbott, Ashley M.
    Gacasan, Samantha B.
    Parrill, Abby L.
    Baker, Daniel L.
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2011, 31 : 76 - 86
  • [45] Virtual Lead Identification of Farnesyltransferase Inhibitors Based on Ligand and Structure-Based Pharmacophore Techniques
    Al-Balas, Qosay A.
    Amawi, Haneen A.
    Hassan, Mohammad A.
    Qandil, Amjad M.
    Almaaytah, Ammar M.
    Mhaidat, Nizar M.
    PHARMACEUTICALS, 2013, 6 (06): : 700 - 715
  • [46] Structure-Based Pharmacophore Design and Virtual Screening for Novel Tubulin Inhibitors with Potential Anticancer Activity
    Zhou, Yunjiang
    Di, Bin
    Niu, Miao-Miao
    MOLECULES, 2019, 24 (17):
  • [47] Novel PARP-1 Inhibitor Scaffolds Disclosed by a Dynamic Structure-Based Pharmacophore Approach
    Baptista, Salete J.
    Silva, Maria M. C.
    Moroni, Elisabetta
    Meli, Massimiliano
    Colombo, Giorgio
    Dinis, Teresa C. P.
    Salvador, Jorge A. R.
    PLOS ONE, 2017, 12 (01):
  • [48] Combining Structure-Based Pharmacophore and In Silico Approaches to Discover Novel Selective Serotonin Reuptake Inhibitors
    Zhou, Zheng-Li
    Liu, Hsuan-Liang
    Wu, Josephine W.
    Tsao, Cheng-Wen
    Chen, Wei-Hsi
    Liu, Kung-Tien
    Ho, Yih
    CHEMICAL BIOLOGY & DRUG DESIGN, 2013, 82 (06) : 705 - 717
  • [49] Novel approach to structure-based pharmacophore search using computational geometry and shape matching techniques
    Ebalunode, Jerry Osagie
    Ouyang, Zheng
    Liang, Jie
    Zheng, Weifan
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2008, 48 (04) : 889 - 901
  • [50] The design of TOPK inhibitors using structure-based pharmacophore modeling and molecular docking based on an MD-refined homology model
    Fakhouri, Lara, I
    Al-Shar'i, Nizar A.
    MOLECULAR DIVERSITY, 2022, 26 (05) : 2679 - 2702